Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 461
Immune Disorders Drugs 195
Cardiovascular Drugs 153
Biopharmaceuticals 132
Infectious Diseases Drugs 116
Endocrine and Metabolic Disorders Drugs 103
Central Nervous System Drugs 102
Drug Discovery 101
Musculoskeletal Disorders Drugs 92
Pharmaceuticals 89
Clinical Trials 89
Hematological Drugs 83
Leukemia Drugs 81
Liver and Kidney Disorders Drugs 74
Lymphoma Drugs 63
Dermatological Drugs 58
Diabetes Drugs 54
Skin Cancer Drugs 49
Brain Cancer Drugs 47
Mental Disorders Drugs 41
Lung Cancer Drugs 40
Respiratory Drugs 38
Immunosuppressive Drugs 36
Gastrointestinal Drugs 34
Drug Delivery 32
Pharmaceutical Intermediates 30
Liver Cancer Drugs 30
Infusions and Injectables 30
Pharmaceutical Manufacturing 27
Analgesics 25
Bladder Cancer Drugs 24
Drugs by Therapeutic Area 23
Antibiotics 23
Kidney Cancer Drugs 22
HIV/AIDS Drugs 22
Breast Cancer Drugs 18
Ovarian Cancer Drugs 17
Colon Cancer Drugs 17
Cervical Cancer Drugs 17
Pancreatic Cancer Drugs 17
Psoriasis Drugs 17
Prostate Cancer Drugs 16
Urological Disorders Drugs 16
Schizophrenia Drugs 15
Thyroid Cancer Drugs 14
Sexual and Reproductive Health Drugs 14
Cancer Vaccines 13
Over the Counter (OTC) Drugs 12
Biosimilars and Biosuperiors 10
Optical Disorders Drugs 8
Generic Drugs 8
Uterine Cancer Drugs 8
Alzheimer's Disease Drugs 8
Transdermal and Transmucosal Drug Delivery 7
Vaccines 7
Cough and Cold Drugs 6
Anti-Obesity Drugs 6
Anxiety Drugs 6
Company Reports 4
Pharmacoeconomics 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



286 reviews

2,373 Results (Page 97 of 119)
- Relevance
  Sort by

BET Inhibitor - Pipeline Insight, 2025

 Drug Pipelines
April 2025
60 Pages
Global

From

€1842EUR$2,000USD£1,557GBP

CCR Inhibitor - Pipeline Insight, 2025

 Clinical Trials
April 2025
120 Pages
Global

From

€1842EUR$2,000USD£1,557GBP

Gastrointestinal Stromal Tumors - Pipeline Insight, 2025

 Clinical Trials
April 2025
85 Pages
Global

From

€1842EUR$2,000USD£1,557GBP

Advanced Gastric Carcinoma - Pipeline Insight, 2025

 Drug Pipelines
April 2025
80 Pages
Global

From

€2303EUR$2,500USD£1,946GBP

Market Spotlight: Myelodysplastic Syndrome (MDS)

 Report
February 2021
60 Pages
Global

€1214EUR$1,318USD£1,026GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Pharma M&A Deals 2023 - Top Themes - Thematic Research

 Report
January 2024
25 Pages
Global

From

€456EUR$495USD£385GBP

Liver Metastases Treatment Market Size, Share & Trends Analysis Report by Treatment Type (Chemotherapy, Immunotherapy), Primary Cancer, Distribution Channel, Region, and Segment Forecasts, 2024-2030

 Report
January 2024
100 Pages
Global

From

€5480EUR$5,950USD£4,631GBP

Lymphoma Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
August 2023
96 Pages
Global

From

€3500EUR$4,071USD£3,061GBP

IgG4-Related Disease - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1382EUR$1,500USD£1,168GBP

Idiopathic Pulmonary Fibrosis - Market Insight, Epidemiology And Market Forecast - 2032

 Report
August 2022
218 Pages
Global

From

€6908EUR$7,500USD£5,838GBP

Immunosuppressant Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
May 2023
106 Pages
Global

From

€3500EUR$4,071USD£3,061GBP

Ischemic Optic Neuropathy Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

 Report
June 2025
245 Pages
Global

From

€4601EUR$4,995USD£3,888GBP

CXCR4 Inhibitor - Pipeline Insight, 2025

 Clinical Trials
April 2025
90 Pages
Global

From

€1382EUR$1,500USD£1,168GBP

Broad Spectrum Chemokine Inhibitor (BSCIs) - Pipeline Insight, 2025

 Clinical Trials
April 2025
90 Pages
Global

From

€1382EUR$1,500USD£1,168GBP

Follicular Lymphoma Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
June 2023
97 Pages
Global

From

€3500EUR$4,071USD£3,061GBP

Non-Hodgkin Lymphoma Therapeutics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
June 2023
93 Pages
Global

From

€3500EUR$4,071USD£3,061GBP

Pharma Industry Mergers and Acquisitions Deals by Top Themes in 2022 - Thematic Intelligence

 Report
February 2023
22 Pages
Global

From

€640EUR$695USD£541GBP

Cancer Immunotherapy Market by Type (Monoclonal Antibodies, Cancer Vaccines, Check Point Inhibitors & Immunomodulators), Application (Lung, Breast, Colorectal, Melanoma, Prostate, Head & Neck), End User (Hospital and Clinics),Regional Outlook- Global Forecast up to 2030

 Report
January 2024
116 Pages
Global

From

€4145EUR$4,500USD£3,503GBP

Orally Disintegrating Tablet Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Product Type

 Report
May 2023
108 Pages
Global

From

€3500EUR$4,071USD£3,061GBP

Progressive Fibrosing Interstitial Lung Disease Market Insight, Epidemiology and Market Forecast - 2032

 Report
August 2022
181 Pages
Global

From

€6908EUR$7,500USD£5,838GBP

2,373 Results (Page 97 of 119)
- 1
- 95
- 96
- 97
- 98
- 99

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.